Atherolive

N/A

Report date: 2022/11/07 20:01:25

Base Information

Drug NameAtherolive
Drug Alias NameOlive Leaf Extracts(University Of Monastir)
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2HypertensionHyperemia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTunisia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Monastir
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Monastir
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2HypertensionHyperemia +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A